News

First Hawaiian Bank recently reduced its Amgen holdings by 39.2%, unloading over 2,100 shares during the first quarter. The ...
Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.
Vantage Wealth bulked up its portfolio by increasing its stake in Amgen by 4.2%, now holding over $21.6 million in shares.
Amgen (NasdaqGS:AMGN) recently announced interim results from its Phase 3 DeLLphi-304 trial for IMDELLTRA, showing ...
The Dow Jones Industrial Average is climbing Friday afternoon with shares of Walmart and Amgen seeing positive gains for the price-weighted average.
Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...
With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...
Many Amgen Inc. (NASDAQ:AMGN) insiders ditched their stock over the past year, which may be of interest to the company's ...
Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...